|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:penicillin
|
|
gptkbp:activities
|
Gram-positive bacteria
inhibits cell wall synthesis
narrow spectrum
some Gram-negative bacteria
|
|
gptkbp:appointed_by
|
injection
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:brand
|
Pfizerpen
|
|
gptkbp:clinical_trial
|
Phase IV
|
|
gptkbp:contraindication
|
penicillin allergy
|
|
gptkbp:developed_by
|
Penicillium fungi
|
|
gptkbp:discovered_by
|
gptkb:Alexander_Fleming
|
|
gptkbp:dissolved
|
water soluble
|
|
gptkbp:first_introduced
|
1940s
|
|
gptkbp:formulation
|
potassium salt
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Penicillin G potassium
|
|
gptkbp:ingredients
|
C16 H17 N2 O4 S
|
|
gptkbp:interacts_with
|
gptkb:methotrexate
gptkb:warfarin
probenecid
|
|
gptkbp:is_available_on
|
powder for injection
|
|
gptkbp:is_effective_against
|
gptkb:fungus
gptkb:VRE
viruses
MRSA
atypical bacteria
|
|
gptkbp:is_tested_for
|
broth microdilution method
disk diffusion method
|
|
gptkbp:is_used_for
|
bacterial infections
|
|
gptkbp:level
|
5.0 to 7.0
|
|
gptkbp:lifespan
|
30 minutes to 1 hour
|
|
gptkbp:manager
|
intravenous
intramuscular
|
|
gptkbp:marketed_as
|
gptkb:Pfizer
|
|
gptkbp:rounds
|
renal
|
|
gptkbp:side_effect
|
gptkb:fandom
nausea
allergic reactions
seizures
diarrhea
thrombocytopenia
neutropenia
superinfection
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:treatment
|
gptkb:healthcare_organization
meningitis
strep throat
endocarditis
|
|
gptkbp:type_of
|
61477-22-9
|
|
gptkbp:weight
|
332.4 g/mol
|